US$ 27.51
are glp 1 drugs lifelong GLP-1 a commitment? Dr. Priya Jaisinghani explains GLP-1 Agonists: Using Semaglutide, Tirzepatide,
Description
Due to the increasing epidemic boost of T2DM in recent years, whose trend will be confirmed in the next decades (3, 4), the need of reducing the CV risk in diabetic patients has become a priority

Nausea was the most common adverse event, significantly higher in the GLP-1RA group compared to placebo

PMID: 3514343

What makes the trial different is its primary endpoint
